Lv21
160 积分 2025-03-19 加入
Nanoarmored Probiotic for Inflammatory Bowel Disease Bacteriotherapy via a Dual-Targeting Host-Microbiota Reprogramming
1个月前
已完结
Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease
3个月前
已完结
Faecalibacterium prausnitzii enzyme reprograms PD-L1 trafficking and sensitizes colorectal cancer to immunotherapy in mice
3个月前
已完结
Microbiota and immune-related adverse events in cancer immunotherapy
3个月前
已完结
Pathophysiology of colitis-associated colorectal cancer
3个月前
已完结
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
3个月前
已完结
Microbial 10-oxostearic acid protects mice against colitis via the nuclear receptor PPARα
3个月前
已完结
Beyond class effects: moving towards drug-level precision in inflammatory bowel disease therapy
3个月前
已完结
Cultivating the microbiome to enhance cancer immunotherapy
3个月前
已完结
Pathophysiology of colitis-associated colorectal cancer
3个月前
已完结
皖公网安备34019202002308
